Antisense Oligonucleotides (ASOs) can be used to block or stimulate mRNA resulting in blocking or promoting the target protein[1].

What is the difference between ASO and siRNA? ASOs have one strand while siRNAs have two[2].

Can help cure various genetic diseases. Key challenge is drug delivery[2].

ASO drugs end with '-rsen'. Antiviral ASOs end with -'virsen'[1].

Can be used to treat an individual patient with a unique disease thus raising regulatory/ethical concerns. Milasen became the first drug approved for a single person named Mila[3].

For more information, please Contact Us.